TRADING UPDATES: Synthomer is cash positive; Arbuthnot lifts outlook
(Alliance News) - The following is a round-up of business updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 11.75p on 30-10-2026 at 17:05:15 |
|---|---|
| Change | 0.00p 0% |
| Buy | 12.00p |
| Sell | 11.50p |
| Last Trade: | Buy 6.00 at 12.00p |
| Day's Volume: | 95,084 |
| Last Close: | 11.75p |
| Open: | 11.75p |
| ISIN: | GB00BFXR4C20 |
| Day's Range | 11.75p - 11.75p |
| 52wk Range: | 6.625p - 12.50p |
| Market Capitalisation: | £25.73m |
| VWAP: | 11.7964p |
| Shares in Issue: | 218.97m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ixico (IXI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 6 | 12.00p | Ordinary |
15:22:04 - 30-Oct-26 |
| Buy* | 10 | 12.00p | Ordinary |
15:06:46 - 30-Oct-26 |
| Buy* | 2 | 12.00p | Ordinary |
14:45:16 - 30-Oct-26 |
| Buy* | 50,000 | 11.755p | Ordinary |
14:41:27 - 30-Oct-26 |
| Unknown* | 5,000 | 11.75p | Ordinary |
14:19:32 - 30-Oct-26 |
| Buy* | 10,000 | 11.96p | Ordinary |
14:09:24 - 30-Oct-26 |
| Sell* | 555 | 11.50p | SI Trade |
14:08:25 - 30-Oct-26 |
| Buy* | 41 | 12.00p | SI Trade |
14:08:25 - 30-Oct-26 |
| Sell* | 494 | 11.50p | SI Trade |
14:08:25 - 30-Oct-26 |
| Sell* | 8 | 11.50p | SI Trade |
14:08:25 - 30-Oct-26 |
Ixico (IXI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Oct 2026 7:00 am | RNS-R | IXICO Presents New Huntington's Disease Research |
| 22nd Oct 2026 7:00 am | RNS | Alzheimer's contract wins |
| 20th Oct 2026 7:00 am | RNS | Trading Update |
| 1st Oct 2026 7:00 am | RNS-R | IXICO present PD research at radiology conference |
| 27th Jul 2026 2:46 pm | RNS | Share option award |
| 15th Jul 2026 12:01 pm | RNS | Director/PDMR Shareholding |
| 13th Jul 2026 7:00 am | RNS | HD Industry Update |
| 7th Jul 2026 7:00 am | RNS | Trading Update |
| 19th Jun 2026 7:00 am | RNS | Exercise of Options |
| 8th Jun 2026 7:00 am | RNS | Scientific advisors & partners update |